Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons

AIDS Patient Care and STDs

Volumn 17, Issue 5, 2003, Pages 245-252

  Power, Rachel ^a,b   Koopman, Cheryl ^a   Volk, Jonathan ^c   Israelski, Dennis M ^a,b   Stone, Louisa ^d   Chesney, Margaret A ^e   Spiegel, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b San Mateo Medical Center   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Networks Counseling Center   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DEMOGRAPHY; DENIAL; FAMILY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRESCRIPTION; SELF REPORT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SUBSTANCE ABUSE;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTI-HIV AGENTS; CALIFORNIA; CROSS-SECTIONAL STUDIES; DENIAL (PSYCHOLOGY); FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; PATIENT COMPLIANCE; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS;

EID: 0038662990     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729103321655890     Document Type: Article

References (29)

1. Hecht FM, Grant RM, Petropoulos CJ, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse transcriptase and protease inhibitors. N Engl J Med 1998;339:307-311.
2. Ickovics JR, Meisler AW. Adherence and retention in AIDS clinical trials: A framework for clinical research and clinical care. J Clin Epidemiol. 1997;50:385-391.
3. Gifford AL, Bormann JE, Shively MJ, Wright, BC, Richman, DD. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-395.
4. Paterson DL, Swindels S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
5. Chesney MA. Compliance: How you can help? HIV Newsline 1997;June:67-72.
6. Singh N, Squier C, Sivek C, Wagener M, Hong Nguyen M, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-269.
7. Stone VE, Adelson-Mitty J, Duefield CA, Steger KA, Stein MD, Mayer KH. Adherence to protease inhibitor (PI) therapy in clinical practice: usefulness of demographics, attitudes and knowledge as predictors. Presented at the 12th World AIDS Conference, Geneva, June 1998.
8. Eldred LJ. The person: Motivators and barriers. Presented at the 12th World AIDS Conference, Geneva, June 1998.
9. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999;13:1099-1107.
10. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-133.
11. Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:117-125.
12. Gordillo V, del Amo J, Soriano V, Gonzlez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
13. Schwarzer F, Dunkel-Schetter C, Kemeny M. The multidimensional nature of received social support in gay men at risk of HIV infection and AIDS. Am J Community Psychol 1994;22:319-339.
14. Fleishman JA, Fogel B. Coping and depressive symptoms among people with AIDS. Health Psychol 1994;13:156-169.
15. Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med 2001;16:83-88.
16. Stein MD, Rich JD, Maksad J, Chen MH, Hu P. Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. Am J Alcohol Abuse 2000;26:195-205.
17. Moatti JP, Carrieri MP, Spire B, et al. Adherence to HAART in french HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. AIDS 2000;14:151-155.
18. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888-891.
19. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instrument. AIDS Care 2000;12:255-266.
20. Ickovics JR, Cameron A, Zackin R, et al. Adherence within ACTG 370: Rates, clinical outcomes and predictors. AACTG Annual Meeting, Alexandria, VA, December 11, 2000.
21. Gallant JE. Adherence to antiretroviral regimens in HIV infected patients: results of a survey among patients and physicians. J Inter Assoc Physicians AIDS Care 1998;4:32-35.
22. Halkitis PN. Advances in the treatment of HIV disease: complexities of adherence and complications for prevention. Health Psychol 1998;20:6-15.
23. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol 1989;56:267-283.
24. Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. Adherence to MAC prophylaxis and antiretroviral therapy in AACTG 362. AACTG Annual Meeting, Alexandria, VA, December 11, 2000.
25. Caudle P. Providing culturally sensitive health care to hispanic clients. Nurse Pract 1993;18:40-51.
26. Sue DW, Sue D. Counseling the Culturally Different. New York: John Wiley & Sons, 1990.
27. Wall TL, Sorensen JL, Batki SL, Delucchi KL, London JA, Chesney MA. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend 1995;37:261-269.
28. Hecht FM, Colfax G, Swanson M, Chesney MA. Adherence and effectiveness of protease inhibitors in clinical practice. Presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, February 1998.
29. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30:S171-S176.